Elevated cerebrospinal fluid total tau in former professional athletes with multiple concussions
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To identify CSF biomarkers that are related to decreased white matter (WM) integrity and poor cognitive performance in former professional athletes with a history of multiple concussions.
Methods Concentrations of phosphorylated tau181, total tau (t-tau), and β-amyloid in the CSF were measured in 3 groups: 22 former professional athletes with multiple concussions (mean ± SD age 55.9 ± 12.2 years), 5 healthy controls (age 57.4 ± 5.2 years), and 12 participants (age 60.0 ± 6.6 years) diagnosed with Alzheimer disease (AD). All participants in the former athletes group underwent diffusion tensor imaging to determine WM tract integrity and completed neuropsychological testing. We divided the former athletes group into those with normal (<300 pg/mL) and high (>300 pg/mL) CSF t-tau.
Results CSF t-tau in the former athletes group was significantly higher than in the healthy control group (349.3 ± 182.6 vs 188.8 ± 39.9 pg/mL, p = 0.003) and significantly lower than in the patients with AD (349.3 ± 182.6 vs 857.0 ± 449.3 pg/mL, p = 0.007). Fractional anisotropy values across all the tracts were significantly lower in the high CSF t-tau group compared to the normal CSF t-tau group (p = 0.036). Participants in the high CSF t-tau group scored significantly lower on the Trail Making Test (TMT) Part B compared to the normal CSF t-tau group (t scores 45.6 ± 18.8 vs 62.3 ± 10.1, p = 0.017).
Conclusion Our findings indicate that former athletes with multiple concussions are at increased risk of elevated levels of CSF t-tau and that high CSF t-tau is associated with reduced WM integrity and worse scores on the TMT Part B.
Glossary
- Aβ1-42=
- β-amyloid1-42;
- AD=
- Alzheimer disease;
- ANOVA=
- analysis of variance;
- AxD=
- axial diffusivity;
- CC=
- corpus callosum;
- Cg=
- cingulum;
- CJD=
- Creutzfeldt-Jakob disease;
- CTE=
- chronic traumatic encephalopathy;
- DTI=
- diffusion tensor imaging;
- DWI=
- diffusion-weighted imaging;
- FA=
- fractional anisotropy;
- FOV=
- field of view;
- HC=
- healthy control;
- MD=
- mean diffusivity;
- p-tau=
- phosphorylated tau181;
- RD=
- radial diffusivity;
- SLF=
- superior longitudinal fasciculus;
- t-tau=
- total tau;
- TBI=
- traumatic brain injury;
- TMT=
- Trail Making Test;
- TR=
- repetition time;
- UHN=
- University Health Network;
- UNC=
- uncinate fasciculus;
- WM=
- white matter
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
CME Course: NPub.org/cmelist
- Received September 21, 2018.
- Accepted in final form February 1, 2019.
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohortN.S.M. Schoonenboom, F.E. Reesink, N.A. Verwey et al.Neurology, December 14, 2011 -
Articles
CSF biomarkers predict a more malignant outcome in Alzheimer diseaseÅ.K. Wallin, K. Blennow, H. Zetterberg et al.Neurology, May 10, 2010 -
Research
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar DegenerationJiasi Vicky Zhang, David J. Irwin, Kaj Blennow et al.Neurology: Clinical Practice, September 04, 2020 -
Research Article
Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous APOE ɛ4 CarriersQiushan Tao, Ting Fang Alvin Ang, Samia C. Akhter-Khan et al.Neurology, July 15, 2021